These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 35078992)

  • 21. Bovine Embryo-Secreted microRNA-30c Is a Potential Non-invasive Biomarker for Hampered Preimplantation Developmental Competence.
    Lin X; Beckers E; Mc Cafferty S; Gansemans Y; Joanna Szymańska K; Chaitanya Pavani K; Catani JP; Van Nieuwerburgh F; Deforce D; De Sutter P; Van Soom A; Peelman L
    Front Genet; 2019; 10():315. PubMed ID: 31024625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
    Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
    Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer.
    Gu YF; Zhang H; Su D; Mo ML; Song P; Zhang F; Zhang SC
    Chin Med J (Engl); 2013 Dec; 126(23):4435-9. PubMed ID: 24286402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary miR-30c-5p as Potential Biomarker for Detection of Oral Squamous Cell Carcinoma.
    Mehterov N; Vladimirov B; Sacconi A; Pulito C; Rucinski M; Blandino G; Sarafian V
    Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vivo role of Rev1 in mutagenesis and carcinogenesis.
    Sasatani M; Zaharieva EK; Kamiya K
    Genes Environ; 2020; 42():9. PubMed ID: 32161626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REV1 is important for the ATR-Chk1 DNA damage response pathway in Xenopus egg extracts.
    DeStephanis D; McLeod M; Yan S
    Biochem Biophys Res Commun; 2015 May; 460(3):609-15. PubMed ID: 25800873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor suppressor p53 induces miR-15a processing to inhibit neuronal apoptosis inhibitory protein (NAIP) in the apoptotic response DNA damage in breast cancer cell.
    Yang L; Zhao W; Wei P; Zuo W; Zhu S
    Am J Transl Res; 2017; 9(2):683-691. PubMed ID: 28337296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.
    Zhang HD; Jiang LH; Hou JC; Zhou SY; Zhong SL; Zhu LP; Wang DD; Yang SJ; He YJ; Mao CF; Yang Y; Wang JY; Zhang Q; Xu HZ; Yu DD; Zhao JH; Tang JH; Ji ZL
    Epigenomics; 2018 Sep; 10(9):1229-1242. PubMed ID: 30182731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance.
    Zhu C; Hou X; Zhu J; Jiang C; Wei W
    Oncol Lett; 2018 Sep; 16(3):3140-3144. PubMed ID: 30127906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microRNA-30c targeting ADAM19 in colorectal cancer.
    Zhang Q; Yu L; Qin D; Huang R; Jiang X; Zou C; Tang Q; Chen Y; Wang G; Wang X; Gao X
    PLoS One; 2015; 10(3):e0120698. PubMed ID: 25799050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of the enhancing effects of miR-93 on resistance of breast cancer MCF-7 cells to adriamycin.
    Wang Q; Su C; Li J; Wei C
    Oncol Lett; 2018 Sep; 16(3):3779-3783. PubMed ID: 30127988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of miR-30c on rats with cerebral ischemia/reperfusion injury by targeting SOX9.
    Zhang M; Zhu Y; Wei M; Liu H
    Pathol Res Pract; 2020 Dec; 216(12):153271. PubMed ID: 33161310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
    Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
    Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells.
    Li J; Zhang Y; Zhao J; Kong F; Chen Y
    Mol Cell Biochem; 2011 Nov; 357(1-2):31-8. PubMed ID: 21594648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-RNA30c negatively regulates REDD1 expression in human hematopoietic and osteoblast cells after gamma-irradiation.
    Li XH; Ha CT; Fu D; Xiao M
    PLoS One; 2012; 7(11):e48700. PubMed ID: 23144934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status.
    Sandhu R; Rein J; D'Arcy M; Herschkowitz JI; Hoadley KA; Troester MA
    Carcinogenesis; 2014 Nov; 35(11):2567-75. PubMed ID: 25123132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.
    Zhang J; Wang X; Wang Y; Peng R; Lin Z; Wang Y; Hu B; Wang J; Shi G
    Oncol Lett; 2017 Jul; 14(1):363-368. PubMed ID: 28693177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.